Xiaosheng

Xiaosheng

China Pharmaceutical University

H-index: 31

Asia-China

About Xiaosheng

Xiaosheng, With an exceptional h-index of 31 and a recent h-index of 28 (since 2020), a distinguished researcher at China Pharmaceutical University, specializes in the field of Bioinformatics, Biostatistics, Cancer Genomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes

A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV- infected hepatocellular carcinoma by multi-omics analysis

Meta-analysis and transcriptome analysis reveal an inverse relationship between Alzheimer’s disease and cancer

Exploring targets and related mechanisms of Scutellaria baicalensis for treating non-small cell lung cancer based on network pharmacology

Identifying Diffuse Glioma Subtypes Based on Pathway Enrichment Evaluation

Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer

Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling

Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties

Xiaosheng Information

University

Position

___

Citations(all)

5660

Citations(since 2020)

5126

Cited By

1981

hIndex(all)

31

hIndex(since 2020)

28

i10Index(all)

59

i10Index(since 2020)

53

Email

University Profile Page

China Pharmaceutical University

Google Scholar

View Google Scholar Profile

Xiaosheng Skills & Research Interests

Bioinformatics

Biostatistics

Cancer Genomics

Top articles of Xiaosheng

Title

Journal

Author(s)

Publication Date

Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes

Computers in Biology and Medicine

Zeinab Abdelrahman

Alaa Abdelaaty

Jiangti Luo

Amy Jayne McKnight

Xiaosheng Wang

2024/3

A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV- infected hepatocellular carcinoma by multi-omics analysis

Genomics

Zijie Wu

Zehua Dong

Jiangti Luo

Weiwei Hu

Yue Tong

...

2024/3

Meta-analysis and transcriptome analysis reveal an inverse relationship between Alzheimer’s disease and cancer

Gui Zheng

Mengli Xu

Zehua Dong

Xiaosheng Wang

2024/2

Exploring targets and related mechanisms of Scutellaria baicalensis for treating non-small cell lung cancer based on network pharmacology

Pharmacological Research - Modern Chinese Medicine

Yuehong Luo

Ting Li

Rongzhuo Long

Qinglong Guo

Libin Wei

...

2024/2

Identifying Diffuse Glioma Subtypes Based on Pathway Enrichment Evaluation

Interdisciplinary Sciences: Computational Life Sciences

Qiushi Feng

Zehua Dong

Rongfang Nie

Xiaosheng Wang

2024/4

Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer

Cellular Oncology

Jiali Lei

Jiangti Luo

Qian Liu

Xiaosheng Wang

2023/10

Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling

Biomolecules

Qiqi Lu

Rongfang Nie

Jiangti Luo

Xiaosheng Wang

Linjun You

2023/1

Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties

Frontiers in Immunology

Zuobing Chen

Wenxiu Cao

Jiangti Luo

Zeinab Abdelrahman

Qiqi Lu

...

2023/6

Mendelian randomization and transcriptomic analysis reveal an inverse causal relationship between Alzheimer’s disease and cancer

Journal of Translational Medicine

Zehua Dong

Mengli Xu

Xu Sun

Xiaosheng Wang

2023/7

Classification of triple-negative breast cancer based on pathway enrichment levels

Medical Oncology

Qian Liu

Xiaosheng Wang

2023/4

PreCanCell: An Ensemble Learning Algorithm for Predicting Cancer and Non-Cancer Cells from Single-Cell Transcriptomes

Computational and Structural Biotechnology Journal

Tao Yang

Qiyu Yan

Rongzhuo Long

Zhixian Liu

Xiaosheng Wang

2023/7

Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling

Computers in Biology and Medicine

Hongjing Ai

Dandan Song

Xiaosheng Wang

2023/4

Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data

Frontiers in Immunology

Mengyuan Li

Xuejiao Gao

Xiaosheng Wang

2023/3

Proteomics-based clustering of lung adenocarcinoma identifies three subtypes with significantly different clinical and molecular features

Clinical and Translational Oncology

Rongzhuo Long

Nayila Abulimiti

Xiaosheng Wang

2023/7

Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis

Computers in Biology and Medicine

Yin He

Xiaosheng Wang

2023/10

Identification of novel pathways and immune profiles related to sarcopenia

Frontiers in Medicine

Zeinab Abdelrahman

Xiaosheng Wang

Daming Wang

Tianfang Zhang

Yue Zhang

...

2023/3

Pan-cancer analysis reveals embryonic and hematopoietic stem cell signatures to distinguish different cancer subtypes

Jiali Lei

Jiangti Luo

Qian Liu

Xiaosheng Wang

2023/7

Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic data

Frontiers in Immunology

Zehua Dong

Qiyu Yan

Wenxiu Cao

Zhixian Liu

Xiaosheng Wang

2022/8

TRPV1 is a potential tumor suppressor for its negative association with tumor proliferation and positive association with antitumor immune responses in pan-cancer

Journal of Oncology

Rongfang Nie

Qian Liu

Xiaosheng Wang

2022/10

Subtyping of Sarcomas Based on Pathway Enrichment Scores in Bulk and Single Cell Transcriptomes

Journal of Translational Medicine

Shengwei Li

Qian Liu

Haiying Zhou

Hui Lu

Xiaosheng Wang

2022/1/29

See List of Professors in Xiaosheng University(China Pharmaceutical University)